Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $12.56 USD
Change Today +0.10 / 0.80%
Volume 584.4K
As of 8:10 PM 05/22/15 All times are local (Market data is delayed by at least 15 minutes).

Earnings & Estimates Summary - MERRIMACK PHARMACEUTICALS IN (MACK)

Merrimack Pharmaceuticals, Inc. to Report Q4, 2014 on Feb 26, 2015
CapIQ 02/26/2015 2:00 PM ET
Merrimack Pharmaceuticals, Inc. to Report Q2, 2014 on Aug 11, 2014
CapIQ 02/26/2015 2:00 PM ET
Merrimack Pharmaceuticals, Inc. to Report Q4, 2013 on Feb 27, 2014
CapIQ 02/26/2015 2:00 PM ET

2013 revenues at Merrimack Pharmaceuticals, Inc. totaled $47.8M USD, while annual losses equaled $1.32 per share.

Quarterly Earnings & Estimates - MERRIMACK PHARMACEUTICALS IN (MACK)

Actuals vs. Estimates for MERRIMACK PHARMACEUTICALS IN MACK

Merrimack Pharmaceuticals, Inc.'s Quarterly Earnings

Merrimack Pharmaceuticals, Inc. reported 1st quarter 2014 losses of $0.27 per share on 05/3/2014.

Annual Earnings & Estimates - MERRIMACK PHARMACEUTICALS IN (MACK)

Actuals vs. Estimates for MERRIMACK PHARMACEUTICALS IN MACK

Merrimack Pharmaceuticals, Inc.'s Annual Earnings

Merrimack Pharmaceuticals, Inc. reported annual 2013 losses of $1.32 per share on 03/1/2014.

Quarterly Revenues - MERRIMACK PHARMACEUTICALS IN (MACK)

Actuals vs. Estimates for MERRIMACK PHARMACEUTICALS IN MACK

Merrimack Pharmaceuticals, Inc.'s Quarterly Revenues

Merrimack Pharmaceuticals, Inc. had 1st quarter 2014 revenues of $13.0M USD. This bettered the $11.9M USD consensus of the 6 analysts covering the company. This was -11.1% below the prior year's 1st quarter results.

Annual Revenues - MERRIMACK PHARMACEUTICALS IN (MACK)

Actuals vs. Estimates for MERRIMACK PHARMACEUTICALS IN MACK

Merrimack Pharmaceuticals, Inc.'s Annual Revenues

Merrimack Pharmaceuticals, Inc. had revenues for the full year 2013 of $47.8M USD. This was -2.3% below the prior year's results.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MACK:US $12.56 USD +0.10

MACK Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for MACK.
View Industry Companies
 

Industry Analysis

MACK

Industry Average

Valuation MACK Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 12.9x
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales 11.2x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MERRIMACK PHARMACEUTICALS IN, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.